
Oncolytics Biotech, Inc (ONCY) last year’s performance of 23.66% is a clear signal for an entertaining trading season.
On Tuesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was -5.83% drop from the session before settling in for the closing price of $1.2. A 52-week range